Bank of America’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Sell |
147,009
-11,925
| -8% | -$13.8K | ﹤0.01% | 5301 |
|
|
2025
Q1 | $175K | Buy |
158,934
+10,266
| +7% | +$11.3K | ﹤0.01% | 5282 |
|
|
2024
Q4 | $256K | Buy |
148,668
+9,944
| +7% | +$17.1K | ﹤0.01% | 5124 |
|
|
2024
Q3 | $344K | Buy |
138,724
+15,999
| +13% | +$39.7K | ﹤0.01% | 4879 |
|
|
2024
Q2 | $297K | Buy |
122,725
+42,109
| +52% | +$102K | ﹤0.01% | 4873 |
|
|
2024
Q1 | $326K | Sell |
80,616
-23,753
| -23% | -$96.2K | ﹤0.01% | 4789 |
|
|
2023
Q4 | $401K | Buy |
104,369
+87,894
| +533% | +$338K | ﹤0.01% | 4764 |
|
|
2023
Q3 | $68.4K | Buy |
16,475
+732
| +5% | +$3.04K | ﹤0.01% | 5511 |
|
|
2023
Q2 | $75.7K | Sell |
15,743
-12,102
| -43% | -$58.2K | ﹤0.01% | 5459 |
|
|
2023
Q1 | $113K | Sell |
27,845
-10,769
| -28% | -$43.7K | ﹤0.01% | 5418 |
|
|
2022
Q4 | $209K | Buy |
38,614
+16,041
| +71% | +$86.6K | ﹤0.01% | 5163 |
|
|
2022
Q3 | $226K | Sell |
22,573
-5,553
| -20% | -$55.6K | ﹤0.01% | 5128 |
|
|
2022
Q2 | $132K | Buy |
28,126
+2,071
| +8% | +$9.72K | ﹤0.01% | 5562 |
|
|
2022
Q1 | $102K | Buy |
26,055
+4,960
| +24% | +$19.4K | ﹤0.01% | 6071 |
|
|
2021
Q4 | $143K | Buy |
21,095
+20,105
| +2,031% | +$136K | ﹤0.01% | 5870 |
|
|
2021
Q3 | $14K | Buy |
+990
| New | +$14K | ﹤0.01% | 6574 |
|